The efficacy of prophylactic intravenous albumin in clinical progress in patients with severe ovarian hyperstimulation syndrome who needed hospitalization.
- Author:
Eun Jeong KIM
1
;
Ha Jung LIM
;
Keun Jai YOO
;
Ji Hong SONG
;
In Ok SONG
;
Jin Yeong KIM
;
Kuol HUR
;
Mi Kyoung KOONG
;
Inn Soo KANG
;
Jong Young JUN
;
Kwang Moon YANG
Author Information
1. Department of Obstetrics and Gynecology, Samsung Cheil Hospital, Sungkyunkwan University School of Medicine and infertility clinic, Korea.
- Publication Type:Original Article
- Keywords:
IVF-ET;
Ovarian hyperstimulation syndrome;
Intravenous albumin
- MeSH:
Estradiol;
Female;
Hospitalization*;
Humans;
Ovarian Hyperstimulation Syndrome*;
Ovulation Induction;
Ovum;
Paracentesis;
Retrospective Studies
- From:Korean Journal of Obstetrics and Gynecology
2002;45(9):1524-1529
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: The purpose of this study is to evaluate the efficacy of prophylactic intravenous albumin in patients with severe ovarian hyperstimulation syndrome (OHSS) who needed hospitalization. METHODS: From January, 1995 to December, 2000, 86 women who underwent COH for IVF-ET were hospitalized for the management of severe OHSS in Samsung Cheil hospital. Among them, twenty one patients were treated with prophylactic intravenous albumin at the day of ovum retrieval, and 65 were not. We analysed clinical symptoms, signs, and hospital courses in the records of 86 patients retrospectively. We compared above variables of prophylactic albumin used group (n=21) with those of non-used group (n=65). RESULTS: Among the indices of ovarian response to ovarian stimulation, serum estradiol (E2) level at the day of hCG injection was significantly higher in prophylactic albumin used group (5805.2+/-1604.4 pg/ml) than non-used group (4125.2+/-1921.5 pg/ml, P<0.05). But the variables which indicate clinical progress (number and amount of paracentesis, amount of used albumin after hospitalization, duration of symptoms, hospital days) showed less severe tendency in prophylactic albumin used group but was not significantly different between two groups. CONCLUSION: Our results indicates that the use of prophylactic intravenous albumin in patients who have risk of severe OHSS had some advantages in favorable clinical progress.
